Neurogesx (NGSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2011 | 12-2010 | 12-2009 | 12-2008 | 12-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -49,540 | N/A | N/A | -26,030 | -31,950 |
| Depreciation Amortization | 1,670 | N/A | N/A | 370 | 280 |
| Other Working Capital | -660 | N/A | N/A | -2,460 | 2,390 |
| Other Operating Activity | 3,430 | 0 | 0 | 870 | 630 |
| Operating Cash Flow | $-45,100 | $N/A | $N/A | $-27,250 | $-28,650 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -110 | N/A | N/A | -200 | -370 |
| Other Investing Activity | 12,280 | 0 | 0 | 7,960 | -18,790 |
| Investing Cash Flow | $12,170 | $N/A | $N/A | $7,760 | $-19,160 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 33,370 | 0 | 0 | -1,550 | 67,390 |
| Financing Cash Flow | $33,370 | $N/A | $N/A | $-1,550 | $67,390 |
| Beginning Cash Position | 8,700 | N/A | N/A | 31,470 | 11,900 |
| End Cash Position | 9,140 | N/A | N/A | 10,430 | 31,470 |
| Net Cash Flow | $440 | $N/A | $N/A | $-21,040 | $19,570 |
| Free Cash Flow | |||||
| Operating Cash Flow | -45,100 | N/A | N/A | -27,250 | -28,650 |
| Free Cash Flow | -45,100 | 0 | 0 | -27,250 | -28,650 |